129 related articles for article (PubMed ID: 4604570)
21. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
[TBL] [Abstract][Full Text] [Related]
22. Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis.
Provost TT; Garrettson LK; Zeschke RH; Rose NR; Tomasi TB
Clin Immunol Immunopathol; 1973 Jul; 1(4):429-45. PubMed ID: 4617643
[No Abstract] [Full Text] [Related]
23. Immunotherapy in recurrent coccidioidomycosis.
Stevens DA; Pappagianis D; Marinkovich VA; Waddell TF
Cell Immunol; 1974 Apr; 12(1):37-48. PubMed ID: 4458962
[No Abstract] [Full Text] [Related]
24. Cell-mediated immunity in patients with amebic abscess of the liver.
Ortiz-Ortiz L; Zamacona G; Sepúlveda B; Capín NR
Clin Immunol Immunopathol; 1975 May; 4(1):127-34. PubMed ID: 165023
[No Abstract] [Full Text] [Related]
25. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
David JR; David RR
Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
[No Abstract] [Full Text] [Related]
26. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
[No Abstract] [Full Text] [Related]
27. Cellular immune response in coccidioidomycosis.
Catanzaro A; Spitler LE; Moser KM
Cell Immunol; 1975 Feb; 15(2):360-71. PubMed ID: 1089482
[No Abstract] [Full Text] [Related]
28. Treatment of mucocutaneous candidasis with transfer factor.
Feigin RD; Shackelford PG; Eisen S; Spitler LE; Pickering LK; Anderson DC
Pediatrics; 1974 Jan; 53(1):63-70. PubMed ID: 4588132
[No Abstract] [Full Text] [Related]
29. [Immunological defence and transfer factor therapy in chronic mucocutaneous candidiasis].
Bläker F; Grob PJ; Hellwege HH; Schulz KH
Dtsch Med Wochenschr; 1973 Mar; 98(9):415-20. PubMed ID: 4691560
[No Abstract] [Full Text] [Related]
30. Immunodeficiencies in chronic muco-cutaneous candidosis.
Lehner T; Wilton JM; Ivanyi L
Immunology; 1972 May; 22(5):775-87. PubMed ID: 4336639
[TBL] [Abstract][Full Text] [Related]
31. The principle of immunopotentiation in treatment of rheumatoid arthritis: effect of transfer factor.
Froland SS; Natvig JB; Hoyeraal HM; Kåss E
Scand J Immunol; 1974; 3(2):223-8. PubMed ID: 4207152
[No Abstract] [Full Text] [Related]
32. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
Elliott ST; Hanifin JM
Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
[TBL] [Abstract][Full Text] [Related]
33. Delayed hypersensitivity in the mouse.
Crowle AJ
Adv Immunol; 1975; 20():197-264. PubMed ID: 47220
[No Abstract] [Full Text] [Related]
34. Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components.
Tannenbaum H; Rocklin RE; Schur PH; Sheffer AL
Clin Exp Immunol; 1976 Dec; 26(3):511-9. PubMed ID: 795577
[TBL] [Abstract][Full Text] [Related]
35. Human skin responses to products of concanavalin A-activated lymphocytes.
Valdimarsson H; Gross NJ
J Immunol; 1973 Aug; 111(2):485-91. PubMed ID: 4717991
[No Abstract] [Full Text] [Related]
36. Delayed hypersensitivity in hepatitis B: clinical correlates of in vitro production of migration inhibition factor.
Irwin GR; Hierholzer WJ; Cimis R; McCollum RW
J Infect Dis; 1974 Dec; 130(6):580-7. PubMed ID: 4610063
[No Abstract] [Full Text] [Related]
37. Photoallergy: a critical survey.
Amos HE
Trans St Johns Hosp Dermatol Soc; 1973; 59(2):147-51. PubMed ID: 4135964
[No Abstract] [Full Text] [Related]
38. Human cells required for macrophage migration inhibitory factor (MIF) production.
Twomey JJ; Lazar S; Rocklin RE
Clin Immunol Immunopathol; 1977 Nov; 8(3):396-404. PubMed ID: 334402
[No Abstract] [Full Text] [Related]
39. The agarose migration inhibition technique for in vitro demonstration of cell-mediated immunity in man. A review.
Clausen JE
Dan Med Bull; 1975 Jul; 22(5):181-94. PubMed ID: 126141
[No Abstract] [Full Text] [Related]
40. Immunological observations in chronic mucocutaneous candidiasis.
Canales L; Middlemas RO; Louro JM; South MA
Lancet; 1969 Sep; 2(7620):567-71. PubMed ID: 4185535
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]